Workflow
HSGC(600774)
icon
Search documents
汉商集团(600774) - 汉商集团第十二届监事会第五次会议决议公告
2025-12-11 08:45
本次会议审议通过了《关于修订<公司章程>并取消监事会的议案》。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 汉商集团股份有限公司(以下简称"公司")于2025年12月5日以网络传输 的方式发出关于召开第十二届监事会第五次会议(以下简称"本次会议")的通 知及会议材料。本次会议于2025年12月10日以通讯表决方式召开,应出席监事3 人,实际出席3人。本次会议的召开符合有关法律、行政法规、部门规章、规范 性文件和《公司章程》的规定。 二、监事会会议审议情况 证券代码:600774 股票简称:汉商集团 编号:2025-043 汉商集团股份有限公司 第十二届监事会第五次会议决议公告 根据《中华人民共和国公司法》(以下简称"《公司法》")、中国证监会《关 于新<公司法>配套制度规则实施相关过渡期安排》《上市公司章程指引》等相关 法律法规的规定,公司将不再设置监事会,由董事会审计委员会行使《公司法》 规定的监事会的职权,《监事会议事规则》相应废止,公司各项规章制度中涉及 监事会、监事的规定不再适用,并相应修 ...
汉商集团(600774) - 汉商集团第十二届董事会第六次会议决议公告
2025-12-11 08:45
证券代码:600774 股票简称:汉商集团 编号:2025-042 汉商集团股份有限公司 第十二届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 汉商集团股份有限公司(以下简称"公司")于 2025 年 12 月 5 日以网络传 输的方式发出关于召开第十二届董事会第六次会议(以下简称"本次会议")的 通知及会议材料。本次会议于 2025 年 12 月 10 日以通讯表决方式召开,应出席 董事 9 人,实际出席 9 人。本次会议的召开符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 二、董事会会议审议情况 (一)本次会议审议通过了《关于修订<公司章程>并取消监事会的议案》。 根据《中华人民共和国公司法》(以下简称"《公司法》")、中国证监会《关 于新<公司法>配套制度规则实施相关过渡期安排》《上市公司章程指引》等相关 法律法规的规定,公司将不再设置监事会,由董事会审计委员会行使《公司法》 规定的监事会的职权,《监事会议事规则》相应废止,公司各项规章制度中涉及 ...
汉商集团(600774) - 汉商集团信息披露暂缓与豁免业务管理制度(2025年12月修订)
2025-12-11 08:31
汉商集团股份有限公司 第二条 公司和其他信息披露义务人(以下统称"信息披露义务人")暂缓、 豁免披露临时报告,在定期报告、临时报告中豁免披露中国证券监督管理委员会 (以下简称"中国证监会")和上海证券交易所规定或者要求披露的内容,适用 本制度。 第三条 信息披露义务人应当真实、准确、完整、及时、公平地披露信息, 不得滥用暂缓或者豁免披露规避信息披露义务、误导投资者,不得实施内幕交易、 操纵市场等违法行为。 第四条 信息披露义务人应当审慎确定信息披露暂缓、豁免事项,履行内部 审核程序后实施。 第二章 暂缓、豁免信息的范围和条件 第五条 信息披露义务人有确实充分的证据证明拟披露的信息涉及国家秘密 或者其他因披露可能导致违反国家保密规定、管理要求的事项(以下统称"国家 秘密"),依法豁免披露。 第六条 信息披露义务人有保守国家秘密的义务,不得通过信息披露、投资 者互动问答、新闻发布、接受采访等任何形式泄露国家秘密,不得以信息涉密为 名进行业务宣传。 1 信息披露暂缓与豁免业务管理制度 第一章 总则 第一条 为规范汉商集团股份有限公司(以下简称"公司")信息披露暂缓与 豁免行为,保证公司依法合规履行信息披露义务,根据 ...
汉商集团(600774.SH):第三季度净利润为770.40万元
Ge Long Hui A P P· 2025-10-30 09:41
Core Viewpoint - Han Commercial Group (600774.SH) reported a decline in revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 251 million, representing a year-on-year decrease of 9.70% [1] - The net profit attributable to shareholders of the listed company was 7.704 million [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -17.9754 million [1]
汉商集团:2025年前三季度净利润约933万元
Mei Ri Jing Ji Xin Wen· 2025-10-30 09:00
Group 1 - The core viewpoint of the article highlights that Han Commercial Group reported a revenue decline of 15.49% year-on-year for the first three quarters of 2025, amounting to approximately 764 million yuan, while net profit attributable to shareholders increased by 274.07% to around 9.33 million yuan [1] - As of the report, Han Commercial Group has a market capitalization of 2.8 billion yuan [1]
汉商集团(600774) - 汉商集团2025年1-3季度经营数据公告
2025-10-30 08:44
证券代码:600774 证券简称:汉商集团 公告编号:2025-041 汉商集团股份有限公司 2025年1-3季度经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 单位:元 币种:人民币 | | | | 主营业务分产品情况 | | | | | --- | --- | --- | --- | --- | --- | --- | | 分产 | 营业收入 | 营业成本 | 毛利率 | 营业收入比 上年同期增 | 营业成本比 上年同期增 | 毛利率比上 年同期增减 | | 品 | | | (%) | 减(%) | 减(%) | (%) | | 中药 | 153,563,002.93 | 95,586,741.17 | 37.75 | -17.62 | 16.11 | 减少 18.09 个百分点 | | 化药 | 364,623,797.42 | 272,998,784.29 | 25.13 | -15.92 | 0.12 | 减少 11.99 个百分点 | 1 | 医疗 | | | | | | 减少 个 0.13 | ...
汉商集团(600774) - 2025 Q3 - 季度财报
2025-10-30 08:40
Financial Performance - The company's operating revenue for the third quarter was CNY 250,876,068.98, a decrease of 9.70% compared to the same period last year[5]. - The total profit for the third quarter was CNY 12,902,755.42, with a year-to-date profit of CNY 19,307,709.99, reflecting an increase of 44.56% year-on-year[5]. - The net profit attributable to shareholders for the third quarter was CNY 7,703,958.19, while the year-to-date net profit reached CNY 9,325,415.72, showing a significant increase of 274.07% compared to the previous year[5]. - Total operating revenue for the first three quarters of 2025 was CNY 763,757,910.80, a decrease of 15.5% compared to CNY 903,786,703.47 in the same period of 2024[25]. - Net profit for the first three quarters of 2025 was CNY 3,215,747.62, compared to a net loss of CNY 4,288,249.20 in the same period of 2024[25]. - Total comprehensive income for the period attributable to the parent company was CNY 9,335,605.36, compared to CNY 2,492,970.62 in the previous period, indicating a significant increase[27]. Earnings and Shareholder Information - The basic earnings per share for the third quarter was CNY 0.0261, and the diluted earnings per share was also CNY 0.0261, both reflecting an increase of 276.19% year-to-date[6]. - Basic and diluted earnings per share increased to CNY 0.0316 from CNY 0.0084 in the previous period, reflecting improved profitability[27]. - The company had a total of 20,652 ordinary shareholders at the end of the reporting period[12]. - The largest shareholder, Wuhan Hanyang Investment Development Group Co., Ltd., held 26.93% of the shares, totaling 79,444,603 shares[13]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,391,880,114.01, a decrease of 3.76% compared to the end of the previous year[6]. - The company's total assets decreased to CNY 3,391,880,114.01 from CNY 3,524,394,269.57 year-over-year[23]. - Current liabilities totaled CNY 1,355,716,508.24, a decrease of 5.1% from CNY 1,428,511,817.17 in the previous year[22]. - Long-term borrowings decreased to CNY 77,009,385.00 from CNY 137,007,387.00, reflecting a reduction of 43.9%[22]. Cash Flow and Financing - The net cash flow from operating activities for the year-to-date was CNY 72,179,925.69, a decrease of 46.92% compared to the previous year[5]. - Net cash flow from operating activities for the first three quarters of 2025 was CNY 72,179,925.69, down 46.8% from CNY 135,984,587.80 in the same period of 2024[30]. - Cash received from the sale of goods and services was CNY 965,036,334.82, a decrease of 15.4% compared to CNY 1,140,921,943.73 in the previous year[29]. - Total cash inflow from operating activities was CNY 1,033,050,416.94, down 13.1% from CNY 1,189,752,224.12 in the previous year[29]. - The company received CNY 427,867,724.22 in cash from borrowings, an increase of 47.2% compared to CNY 290,745,189.74 in the previous year[30]. Operational Challenges - The net cash flow from operating activities for the year-to-date was CNY 72,179,925.69, a decrease of 46.92% compared to the previous year[5]. - The company has a judicial freeze on several bank accounts, with balances as low as RMB 1.03, indicating potential liquidity issues[19]. - The company has pledged multiple properties as collateral for loans, including properties in Hanyang District, indicating a strategy to secure financing through asset-backed loans[16][17][18]. - The company has short-term loans totaling RMB 1,000,000.00 from Guangda Bank, RMB 32,000,000.00 from Agricultural Bank of China, and RMB 81,000,000.00 from Industrial Bank, indicating significant reliance on bank financing[16][17][18]. Other Financial Metrics - The weighted average return on equity at the end of the reporting period was 0.4624%, an increase of 0.82 percentage points compared to the end of the previous year[6]. - Research and development expenses for the first three quarters of 2025 were CNY 24,078,584.70, down 23.1% from CNY 31,267,422.13 in 2024[25]. - The company reported a significant increase in other income, totaling CNY 20,337,822.70 compared to CNY 10,672,474.97 in the previous year[25]. - The company experienced a credit impairment loss of CNY -3,442,603.40, contrasting with a gain of CNY 5,005,926.63 in the previous year[26]. - The company has not engaged in any share lending or borrowing activities during the reporting period, indicating a stable shareholder structure[15].
181只股中线走稳 站上半年线
Core Points - The Shanghai Composite Index is at 3927.63 points, slightly down by 0.16%, with a total trading volume of 1.2446 trillion yuan [1] - A total of 181 A-shares have surpassed the half-year line, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - Li Min Co., Ltd. (002734) has a deviation rate of 4.31% with a price increase of 6.27% [1] - Yuanda Environmental Protection (600292) shows a deviation rate of 3.35% and a price increase of 3.93% [1] - Oriental Carbon (920175) has a deviation rate of 3.28% with an 8.17% price increase [1] Trading Activity - The total trading volume for A-shares today is reported at 1.2446 trillion yuan [1] - The stocks with the smallest deviation rates include Lian Ke Technology, Lingkang Pharmaceutical, and Publishing Media, which have just crossed the half-year line [1] Deviation Rate Rankings - The top stocks with the highest deviation rates include: - Li Min Co., Ltd. (002734) at 4.31% - Yuanda Environmental Protection (600292) at 3.35% - Oriental Carbon (920175) at 3.28% [1] - Other notable stocks with significant price increases and deviation rates include: - Han Commercial Group (600774) at 3.19% - Rui Pu Biological (300119) at 2.99% [1]
汉商集团(600774) - 汉商集团关于提供担保进展情况的公告
2025-10-08 08:15
证券代码:600774 股票简称:汉商集团 编号:2025-040 汉商集团股份有限公司 关于提供担保进展情况的公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者重大遗漏, 并对其内容的真实、准确和完整承担法律责任。 重要内容提示: 1、担保人:汉商集团股份有限公司(以下简称"公司")的全资子公司成都迪康药业 股份有限公司(以下简称"迪康药业") 2、被担保人:重庆迪康长江制药有限公司(以下简称"迪康长江") 3、新增担保金额:3,000万元 5、是否有反担保:无 一、担保情况概述 (一)担保基本情况 担保人与被担保人的关系:迪康长江为迪康药业的全资子公司。 迪康药业在公司股东大会批准担保额度内,为迪康长江在重庆三峡银行股 份有限公司万州分行贷款 3,000 万元提供保证担保,并与重庆三峡银行股份有 限公司万州分行签订《保证合同》(合同编号:渝三银 BZC02262025210002101 号)。 (二)年度预计担保使用情况 经公司 2025 年 4 月 29 日召开的 2024 年年度股东会审议通过的《关于续展 及新增担保额度的议案》,公司与控股子公司或控股子公司之间相互提供担保, 预计 ...
拆解卓尔系中报:净利分化、负债率偏高
Bei Jing Shang Bao· 2025-09-04 16:11
Core Viewpoint - Under the leadership of entrepreneur Yan Zhi, Zall Holdings has become a well-known comprehensive enterprise group, with its main businesses including trade logistics and intelligent manufacturing. The performance of its three listed companies has shown divergence in the first half of 2025, with Zall Intelligent Network performing the best, while the other two A-share companies showed weaker results [1][2]. Group 1: Company Performance - Zall Intelligent Network achieved a revenue of approximately 90.92 billion yuan, a year-on-year increase of 33.17%, and a net profit of about 97.05 million yuan, up 94.82% year-on-year [2]. - Han Commercial Group reported a revenue of approximately 513 million yuan, a year-on-year decline of 18.06%, and a net profit of about 1.62 million yuan, down 80.95% year-on-year [2]. - Huazhong CNC's revenue was approximately 554 million yuan, a year-on-year decrease of 11.91%, with a net loss of about 81.45 million yuan, although it showed a reduction in losses compared to the previous year [2][3]. Group 2: Financial Ratios - Zall Intelligent Network's total assets were 69.78 billion yuan, with total liabilities of 55.40 billion yuan, resulting in an asset-liability ratio of 79.39% [4]. - Huazhong CNC had total assets of 4.45 billion yuan and total liabilities of 2.76 billion yuan, leading to an asset-liability ratio of 62.12% [4]. - Han Commercial Group's total assets were 3.42 billion yuan, with total liabilities of 1.62 billion yuan, resulting in an asset-liability ratio of 47.4% [4]. Group 3: Business Strategies and Developments - Han Commercial Group is advancing a dual business strategy of "big health + big commerce," focusing on pharmaceuticals, medical devices, and commercial operations [5]. - Zall Intelligent Network is involved in wholesale trade, supply chain management, and logistics, with sales costs increasing from approximately 67.91 billion yuan to about 90.64 billion yuan, a growth of over 30% [5]. - Zall Holdings has been recognized in various rankings, including being listed 46th in the 2025 China Private Enterprises 500 and 160th in the 2025 Fortune China 500 [6]. Group 4: Market Capitalization - As of September 3, Huazhong CNC had a market capitalization of 5.883 billion yuan, Han Commercial Group had 2.9 billion yuan, and Zall Intelligent Network had a market capitalization of 1.612 billion Hong Kong dollars, totaling approximately 10.26 billion yuan [7].